BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 38136573)

  • 21. BMSCs and hematopoiesis.
    García-García A; de Castillejo CL; Méndez-Ferrer S
    Immunol Lett; 2015 Dec; 168(2):129-35. PubMed ID: 26192443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment.
    Tratwal J; Rojas-Sutterlin S; Bataclan C; Blum S; Naveiras O
    Best Pract Res Clin Endocrinol Metab; 2021 Jul; 35(4):101564. PubMed ID: 34417114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal Stem Cells in the Tumor Microenvironment.
    Atiya H; Frisbie L; Pressimone C; Coffman L
    Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.
    Kemp K; Morse R; Wexler S; Cox C; Mallam E; Hows J; Donaldson C
    Ann Hematol; 2010 Jul; 89(7):701-13. PubMed ID: 20119670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
    Brennen WN; Kisteman LN; Isaacs JT
    Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The marrow stem cell niche in normal and malignant hematopoiesis.
    Kaushansky K; Zhan H
    Ann N Y Acad Sci; 2020 Apr; 1466(1):17-23. PubMed ID: 30767234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise Review: The Malignant Hematopoietic Stem Cell Niche.
    Yao JC; Link DC
    Stem Cells; 2017 Jan; 35(1):3-8. PubMed ID: 27647718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy.
    Mohammadalipour A; Dumbali SP; Wenzel PL
    Front Cell Dev Biol; 2020; 8():603292. PubMed ID: 33365311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
    Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
    Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.
    Poggi A; Giuliani M
    Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27834810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells.
    Fujishiro A; Iwasa M; Fujii S; Maekawa T; Andoh A; Tohyama K; Takaori-Kondo A; Miura Y
    Int J Hematol; 2020 Sep; 112(3):316-330. PubMed ID: 32572826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.
    Li AJ; Calvi LM
    Exp Hematol; 2017 Nov; 55():3-18. PubMed ID: 28826860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging trends in chromatin remodeler plasticity in mesenchymal stromal cell function.
    Chakraborty S; Sinha S; Sengupta A
    FASEB J; 2021 Jan; 35(1):e21234. PubMed ID: 33337557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic
    Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
    Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells?
    Goodarzi A; Valikhani M; Amiri F; Safari A
    Cell Commun Signal; 2022 Mar; 20(1):21. PubMed ID: 35236376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extracellular matrix: A key player in the pathogenesis of hematologic malignancies.
    Sidhu I; Barwe SP; Gopalakrishnapillai A
    Blood Rev; 2021 Jul; 48():100787. PubMed ID: 33317863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bone marrow microenvironment in health and disease at a glance.
    Kumar R; Godavarthy PS; Krause DS
    J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29472498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stromal cell senescence in haematological malignancies.
    Plakhova N; Panagopoulos V; Vandyke K; Zannettino ACW; Mrozik KM
    Cancer Metastasis Rev; 2023 Mar; 42(1):277-296. PubMed ID: 36622509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.